REXULTI

This brand name is authorized in Australia, Brazil, Canada, Ecuador, Hong Kong, Israel, Japan, Singapore, Turkey, United States, South Africa

Active ingredients

The drug REXULTI contains one active pharmaceutical ingredient (API):

1 Brexpiprazole UNII 2J3YBM1K8C - BREXPIPRAZOLE

Brexpiprazole is an atypical antipsychotic agent. The pharmacology of brexpiprazole is believed to be mediated by a modulatory activity at the serotonin and dopamine systems that combines partial agonist activity at serotonergic 5-HT1A and at dopaminergic D2 receptors with antagonist activity at serotonergic 5-HT2A receptors, with similar high affinities at all of these receptors. Read about Brexpiprazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
REXULTI Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AX16		N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11184P, 11188W, 11189X, 11190Y
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 524220080004407, 524220080004507, 524220080004607, 524220080004707, 524220080004807, 524220080004907
Country: CA	Health Products and Food Branch	Identifier(s): 02461749, 02461757, 02461765, 02461773, 02461781, 02461803, 02485923
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4813-MEE-0919, 4867-MEE-1119, 5014-MEE-0320, 5015-MEE-0320, 5191-MEE-0620, 5192-MEE-0620
Country: HK	Department of Health Drug Office	Identifier(s): 66303, 66304, 66305, 66306, 66307, 66308
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8635, 8636, 8637, 8638, 9341
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179058F1020, 1179058F2027, 1179058F3023, 1179058F4020, 1179058F5026
Country: SG	Health Sciences Authority	Identifier(s): 15763P, 15764P, 15765P, 15766P, 15767P, 15768P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8680683090028, 8680683090035, 8680683090042, 8680683090059, 8680683090066
Country: US	FDA, National Drug Code	Identifier(s): 59148-035, 59148-036, 59148-037, 59148-038, 59148-039, 59148-040
Country: ZA	Health Products Regulatory Authority	Identifier(s): 51/2.6.5/0502, 51/2.6.5/0503, 51/2.6.5/0504, 51/2.6.5/0505